all names

Gyre Pharmaceuticals organisation

Named in 1 report across 1 story - 7 Aug

Closest companions, sized by how often they share a report with Gyre Pharmaceuticals. Lines between the outer names are their own relationships - names that appear together even without Gyre Pharmaceuticals.

Chuck Padala and Cullgen Inc share 1 reportAstellas Pharma Inc and Australia share 1 reportChina and Company Nasdaq share 1 reportChina and China National Medical Products Administration share 1 reportAustralia and Beijing share 1 reportCullgen Inc and Exchange Commission share 1 reportAustralia and Development Expense share 1 reportBeijing and Cullgen Inc share 1 reportChuck Padala and Exchange Commission share 1 reportChuck Padala and Development Expense share 1 reportCullgen Inc and Development Expense share 1 reportCompany Nasdaq and Development Expense share 1 reportAustralia and Exchange Commission share 1 reportAstellas Pharma Inc and China share 1 reportBeijing and Exchange Commission share 1 reportBeijing and Development Expense share 1 reportBeijing and China National Medical Products Administration share 1 reportAstellas Pharma Inc and Development Expense share 1 reportAstellas Pharma Inc and Company Nasdaq share 1 reportChina National Medical Products Administration and Company Nasdaq share 1 reportAstellas Pharma Inc and Chuck Padala share 1 reportAstellas Pharma Inc and China National Medical Products Administration share 1 reportChina National Medical Products Administration and Cullgen Inc share 1 reportChina and Development Expense share 1 reportAustralia and Chuck Padala share 1 reportDevelopment Expense and Exchange Commission share 1 reportChina and Chuck Padala share 1 reportAstellas Pharma Inc and Beijing share 1 reportAustralia and China National Medical Products Administration share 1 reportBeijing and China share 1 reportChina National Medical Products Administration and Chuck Padala share 1 reportChuck Padala and Company Nasdaq share 1 reportChina and Exchange Commission share 1 reportBeijing and Company Nasdaq share 1 reportAstellas Pharma Inc and Exchange Commission share 1 reportChina National Medical Products Administration and Development Expense share 1 reportCompany Nasdaq and Cullgen Inc share 1 reportChina National Medical Products Administration and Exchange Commission share 1 reportAustralia and Company Nasdaq share 1 reportCompany Nasdaq and Exchange Commission share 1 reportGyre PharmaceuticalsAstellas Pharma I…Astellas Pharma Inc - 1 shared report (organization)AustraliaAustralia - 1 shared report (place)BeijingBeijing - 1 shared report (place)ChinaChina - 1 shared report (place)China Natio…China National Medical Products Administration - 1 shared report (organization)Chuck PadalaChuck Padala - 1 shared report (person)Company Nas…Company Nasdaq - 1 shared report (organization)Cullgen IncCullgen Inc - 1 shared report (organization)Development…Development Expense - 1 shared report (organization)Exchange Co…Exchange Commission - 1 shared report (organization)

The stories

Gyre Therapeutics Inc.: Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

1 outlets1 report names Gyre Pharmaceuticals7 Aug

Who keeps naming them

finanznachrichten.de1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.